Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
POW ARCHIVE WEEK: Papers: 20 May 2023 - 26 May 2023
RESEARCH TYPE:Translational
STUDY TYPE:Human Studies, Neurobiology, Pharmacology/Drug Development
PAIN TYPE:Migraine/Headache
DATE PUBLISHED: 2023 May 23
JOURNAL:J Neurol
PUBMED: 37219606
In real-world studies, it is unclear whether galcanezumab has a significant effect in the first week after administration.
